NCT06377202View on ClinicalTrials.gov

Long-Term Follow-Up Safety Study of Subjects Treated with SynKIR-110 in Cancer Studies

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

November 15, 2023

Primary Completion Date

December 15, 2038

Study Completion Date

December 15, 2038

Conditions
Cancer
Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

Sponsors
All Listed Sponsors
lead

Verismo Therapeutics

INDUSTRY

NCT06377202 - Long-Term Follow-Up Safety Study of Subjects Treated with SynKIR-110 in Cancer Studies | Biotech Hunter | Biotech Hunter